Related references
Note: Only part of the references are listed.Immunogenicity of small-cell lung cancer associates with STING pathway activation and is enhanced by ATR and TOP1 inhibition
Xuetao Li et al.
CANCER MEDICINE (2023)
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
Carminia Maria Della Corte et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Human Cancer Cells Sense Cytosolic Nucleic Acids Through the RIG-I-MAVS Pathway and cGAS-STING Pathway
Yuan Qiao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
cGAS-STING pathway expression as a prognostic tool in NSCLC
Kristine Raaby Gammelgaard et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer
Li Zhou et al.
CANCER LETTERS (2021)
Non-Small Cell Lung Cancer, Version 2.2021 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses
Erik H. Knelson et al.
CANCERS (2021)
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
Anish Thomas et al.
CANCER CELL (2021)
PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer
N. Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them
Shan-Shan Zou et al.
PHARMACOLOGICAL RESEARCH (2021)
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
Ukhyun Jo et al.
MOLECULAR CANCER THERAPEUTICS (2021)
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING
Yong Zhang et al.
CANCER DISCOVERY (2021)
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Takashi Nakamura et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
HER2-targeted therapies - a role beyond breast cancer
Do-Youn Oh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
Carminia M. Della Corte et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Selective reactivation of STING signaling to target Merkel cell carcinoma
Wei Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer
Fang Ma et al.
FRONTIERS IN GENETICS (2020)
Relapse-related molecular signature in early-stage lung adenocarcinomas based on base excision repair, stimulator of interferon genes pathway and tumor-infiltrating lymphocytes
Bo Yang et al.
CANCER SCIENCE (2020)
Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
Henrique Lemos et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches
Ranya Barayan et al.
JOURNAL OF THORACIC DISEASE (2020)
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Roman M. Chabanon et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
Triparna Sen et al.
CANCER DISCOVERY (2019)
Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity
Lifeng Li et al.
MOLECULAR CANCER (2019)
HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity
Shiying Wu et al.
NATURE CELL BIOLOGY (2019)
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors
Timo Reislander et al.
NATURE COMMUNICATIONS (2019)
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
Hannah Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
Anna F. Farago et al.
CANCER DISCOVERY (2019)
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Yang Liu et al.
NATURE COMMUNICATIONS (2019)
STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability
Diana Rose E. Ranoa et al.
CANCER RESEARCH (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Shunsuke Kitapma et al.
CANCER DISCOVERY (2019)
Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression
Dewan Md Sakib Hossain et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment
Arunakumar Gangaplara et al.
PLOS PATHOGENS (2018)
Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches
Li Teng Khoo et al.
EMBO REPORTS (2018)
Tumor cGAMP Awakens the Natural Killers
Shriram K. Sundararaman et al.
IMMUNITY (2018)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus et al.
IMMUNITY (2018)
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa et al.
NATURE REVIEWS CANCER (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms
T. Kordbacheh et al.
ANNALS OF ONCOLOGY (2018)
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression
Chin-An Yang et al.
ONCOLOGY (2017)
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1
Erkin Erdal et al.
GENES & DEVELOPMENT (2017)
Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
cGAS surveillance of micronuclei links genome instability to innate immunity
Karen J. Mackenzie et al.
NATURE (2017)
Mitotic progression following DNA damage enables pattern recognition within micronuclei
Shane M. Harding et al.
NATURE (2017)
Cytoplasmic chromatin triggers inflammation in senescence and cancer
Zhixun Dou et al.
NATURE (2017)
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Selene Gluck et al.
NATURE CELL BIOLOGY (2017)
cGAS is essential for the antitumor effect of immune checkpoint blockade
Hua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
cGAS is essential for cellular senescence
Hui Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Evolutionary Origins of cGAS-STING Signaling
Shally R. Margolis et al.
TRENDS IN IMMUNOLOGY (2017)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
Decreased expression of STING predicts poor prognosis in patients with gastric cancer
Shushu Song et al.
SCIENTIFIC REPORTS (2017)
Manipulation of Innate and Adaptive Immunity through Cancer Vaccines
Elias J. Sayour et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Microsatellite instability status predicts response to anti-PD-1/PD-L1 therapy regardless the histotype: A comment on recent advances
Semir Vranic
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2017)
CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib
Triparna Sen et al.
CANCER RESEARCH (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
Jason R. Baird et al.
CANCER RESEARCH (2016)
Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis
Tianli Xia et al.
CANCER RESEARCH (2016)
Diminished but not dead: chemotherapy for the treatment of NSCLC
Roy S. Herbst et al.
LANCET ONCOLOGY (2016)
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Scott J. Antonia et al.
LANCET ONCOLOGY (2016)
The microbiome and innate immunity
Christoph A. Thaiss et al.
NATURE (2016)
LKB1 loss links serine metabolism to DNA methylation and tumorigenesis
Filippos Kottakis et al.
NATURE (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
Yang Bu et al.
PLOS ONE (2016)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
In-situ tumor vaccination: Bringing the fight to the tumor
Robert H. Pierce et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
Gordon J. Freeman et al.
IMMUNOLOGICAL REVIEWS (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jerome Galon et al.
JOURNAL OF PATHOLOGY (2014)
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
David B. Shackelford et al.
CANCER CELL (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate
Wei Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Stephen R. Mattarollo et al.
CANCER RESEARCH (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming
Silvia Lorenzi et al.
JOURNAL OF IMMUNOLOGY (2011)
Type I interferons inhibit the generation of tumor-associated macrophages
Lance U'Ren et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Prolonged Antigen Storage Endows Merocytic Dendritic Cells with Enhanced Capacity To Prime Anti-Tumor Responses in Tumor-Bearing Mice
Rachel A. Reboulet et al.
JOURNAL OF IMMUNOLOGY (2010)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module
Daeho Park et al.
NATURE (2007)
Share Paper
